Natural CBD supplements in Poland, what to watch out for before purchasing (red flags 2026)

The Polish market for CBD oils in 2026 has real value, but it also carries real risks of fraud. A study by the University of Pennsylvania published in JAMA (Bonn-Miller et al., 2017) found that only 30.95% of CBD products from online sales had labels consistent with the actual cannabidiol content, meaning nearly 7 out of 10 products were mislabeled. This article focuses solely on warning signs: how a fake COA works, how an isolate pretends to be full spectrum, why MLM rewards recruitment over product quality, and what FDA warning letters mean for the Polish consumer. The tone of this text is calm demystification, not panic: the Polish consumer in 2026 has real protection tools, from UOKiK through GIS to the EU Novel Food register, and it is enough to know where to look before clicking 'Buy now.'

KEY INFORMATION
• 69% of CBD products had labels inconsistent with the actual cannabidiol content (Bonn-Miller et al., University of Pennsylvania, JAMA 2017).
• Brak COA z akredytowanego laboratorium ISO 17025 i numerem partii dyskwalifikuje produkt.
• The promise of 'treatment' on a CBD package violates EU Regulation 1924/2006 on health claims.
• Oil 10% below 30 zlotys makes no economic sense for production, so it likely does not contain real CBD.
• FDA regularnie wystawia warning letters markom CBD za nieuprawnione roszczenia zdrowotne od 2015 roku.

What are the most common marketing traps in the CBD market in Poland?

CBD marketing often relies on a medical narrative that the manufacturer has no right to use. According to a report from the Centre for Medicinal Cannabis (CMC UK, 2019) as much as 62% of tested British CBD products did not have content consistent with the label, and similar conclusions are repeated in analyses by UOKiK and the German BVL. Most traps are not about falsified composition, but rather advertising messages designed to create subconscious associations with medicine.

Three mechanisms are most commonly repeated. The first is the "medicalization" of packaging: a white background, a green cross, a drop in the shape of a capsule. The second is a quasi-scientific language: words like "therapy", "clinically proven", "wonder molecule". The third is a false authority, where the producer refers to non-existent "institutes" or studies without providing a source.

Certain types of statements should not appear on the label of a legal CBD product at all, as they directly violate EU Regulation 1924/2006 and the Polish Food Safety Act:

• "Cures depression, anxiety, cancer, epilepsy, multiple sclerosis" - statements reserved exclusively for registered medications.
• "Wonder molecule", "natural remedy", "medical formula" - medicalizing phrases that are inconsistent with EFSA Health Claims.
• "Works from the first day", "100% effectiveness" - promises of effect that violate advertising law.
• "Approved by WHO" - WHO does not approve commercial supplements; in 2018, it only issued a general safety report on CBD.

A producer who violates this rule risks being placed on the GIS warning list, and in extreme cases, an order to withdraw from the market. According to a report Office of Competition and Consumer Protection from December 2024, the most common basis for sanctions against CBD sellers are indeed unauthorized health claims in store descriptions and on packaging, both in brick-and-mortar stores and on cross-border marketplace platforms.

Dlaczego brak certyfikatu COA to czerwona flaga numer 1?

The lack of a Certificate of Analysis (COA) automatically disqualifies a CBD product, because without independent testing, you are buying randomness instead of a supplement. In a study by the University of Pennsylvania (JAMA, 2017) of 84 tested CBD oils, as much as 42.85% contained less cannabidiol than declared on the label, while 26.19% had more. The COA must come from a laboratory accredited to ISO/IEC 17025 standards, which is the international standard for the competence of testing laboratories. In Poland, the list of accredited entities is maintained by the Polish Center for Accreditation (PCA).

A reliable COA has five features: the name and accreditation number of the laboratory (for example, PCA, A2LA, UKAS), a batch number consistent with the product packaging, a sampling date and an analysis date not older than 12 months, a full cannabinoid profile (CBD, THC, CBG, CBN, CBC) along with heavy metals, pesticides, solvents, and microbiology, as well as the signature or identifier of the analyst with a unique report number. If you see a "certified lab" logo on the PDF without an accreditation number, you are likely looking at an unsupported graphic.

A fake COA reveals itself through several tricks: the same file for all batches of the product, a generic template without the laboratory's logo, a missing date, tests only for cannabinoids without heavy metals and pesticides, or a file secured against copying to hide details. Project CBD It also warns against "universal" COAs, allegedly signed by laboratories from outside Europe. In an editorial review of dozens of CBD stores in Polish Google results, only a minority provided COAs with batch numbers consistent with the packaging, while the rest either had no certificate at all or showed a "general quality report" without linking to a specific bottle.

How to recognize a CBD isolate pretending to be full spectrum oil (red flag number 2)?

CBD isolate is pure cannabidiol with a purity of about 99%, devoid of other cannabinoids and terpenes, which the producer buys wholesale 2-3 times cheaper than broad-spectrum extract and sells as "premium full spectrum". Independent laboratories have repeatedly shown that some products labeled as "full spectrum" in online sales actually contain only CBD. The difference is financially significant because full spectrum provides the theoretical entourage effect, or the synergy of cannabinoids and terpenes described by Russo (British Journal of Pharmacology, 2011). An isolate does not offer such synergy, so you are paying for a label that the product does not fulfill.

The visual test is simple. Full spectrum has a dark color, ranging from olive green to brown, a distinct herbal aroma, slightly bitter, and after shaking the bottle, the oil remains slightly cloudy. An isolate suspended in MCT is transparent, almost like yellow-tinted water, with a neutral, oily taste without any plant notes.

In the COA of a reliable full spectrum, detectable amounts of CBG (usually 0.1-0.8%), CBN (0.05-0.3%), CBC (0.1-0.5%), trace THC (up to 0.2-0.3%), and results for terpenes such as myrcene, beta-caryophyllene, limonene, or pinene can be seen. If the COA shows only the value of CBD without other cannabinoids, the bottle contains an isolate, regardless of what the label claims. Russo pointed out in his review that terpenes and minor cannabinoids can act synergistically with the main components of cannabis in pain, inflammation, and anxiety, so selling an isolate as full spectrum deprives the consumer of that potential synergy for which they pay a premium price.

Why do medical claims by CBD producers violate the law (red flag number 3)?

Any statement like "cures insomnia" or "helps with depression" on a CBD package violates EU Regulation 1924/2006 on nutrition and health claims. The European Food Safety Authority (EFSA) in 2026 still has not approved any health claim for CBD, so no producer in the EU has the right to claim that their product cures anything. Sellers violate this ban in three ways: directly on the packaging ("cures anxiety"), in the store description or on the producer's blog ("helps with epilepsy"), and through customer "testimonials" that effectively formulate health claims. All three are pursued by UOKiK and GIS.

EFSA specifically prohibits four types of claims:

• Claims about preventing diseases, such as "protects against Alzheimer's".
• Claims about treating diseases, such as "cures multiple sclerosis".
• Non-specific claims without scientific backing, such as "wonder" or "almighty".
• Citing clinical studies without including them and without EFSA approval.

A producer is allowed to use only general statements about nutritional properties or wellness support, as long as they do not suggest therapeutic action. Phrases like "natural hemp seed extract", "rich in cannabinoids", or "for those who value a plant-based diet" are permissible. "Facilitates falling asleep" is not, as this is a functional claim requiring authorization. As part of the implementation of the Omnibus Directive (EU 2019/2161), UOKiK since 2023 treats the lack of information that a health claim is not authorized by EFSA as a separate violation, independent of the penalty for the claim itself.

Dlaczego podejrzanie niska cena oleju CBD to czerwona flaga numer 4?

The cost of producing 10 ml of 10% CBD oil (1000 mg) using CO2 extraction, in an MCT base, with laboratory testing, is estimated on the market at several dozen zlotys net. Adding VAT and the margin of the producer and retailer, a shelf price of 79-149 PLN is a realistic range for quality broad-spectrum oil in the EU. Oil offered for 19, 25, or 29 PLN has no mathematical chance of covering the costs of raw materials, extraction, bottling, and testing. The most likely scenarios are oil from hemp seeds without cannabidiol, CBD isolate without COA and without contamination control, or a product imported without compliance with the European Novel Food standard.

An absurdly high price, for example, a luxury 30 ml oil for 999 PLN, can also be a trap if it is not accompanied by extensive documentation, organic certification, and a unique formulation. Premium should look like premium based on specifics, not flashy packaging.

Dlaczego brak danych producenta to czerwona flaga numer 5?

Every product introduced to the EU market must have a responsible entity with an address in the Union: for food, this is required by Regulation 1169/2011, and for cosmetics by Regulation 1223/2009. The absence of a company name, postal address, REGON number, or European equivalent is not only a red flag but a direct violation of the law. Without a responsible entity, you have no recipient for complaints, you do not know whom to report adverse effects to, and you have no certainty about where the product was made or whether it meets GMP standards. UOKiK in communications from 2024 pointed out that some verified CBD offers on popular marketplaces did not contain complete data of the responsible entity.

The packaging should contain six elements: the full name of the company, postal address with a code and city within the EU, batch number or LOT, date of minimum durability or suitability, ingredients in order from highest to lowest content, and net capacity with safety warnings.

Verifying a Polish producer takes two minutes in free registries. KRS or CEIDG will confirm the existence of the company, and the white VAT list on the website podatki.gov.pl will show tax activity. Lack of entries or a company registered just the day before is a classic warning sign, especially with offers of "miracle oils" from unknown branding.

How to recognize hidden CBD dropshipping (red flag number 6)?

Dropshipping is a model in which the seller accepts the order and payment, but the product is shipped by an intermediary from an external warehouse, most often outside the EU. The model itself is legal for many categories of goods, but it generates specific risks with CBD: the product is not subject to European control, the seller does not know the batch, and the COA may be outdated or fabricated. According to the European Industrial Hemp Association (EIHA, 2023) a significant portion of CBD offers on marketplace platforms comes from dropshipping outside the EU, where Regulation 1169/2011 and Novel Food do not apply. The consumer sees a "Polish store" and receives a package from a Polish warehouse, although the product physically originated outside the European quality chain.

Hidden dropshipping reveals several signals: lack of a physical address in the footer of the site, only a contact form, delivery time of 14-30 days without explanation, identical product photos as on AliExpress or eBay, a return policy requiring sending back to a foreign address at the customer's expense, and lack of company data in the Polish KRS or CEIDG despite declared Polish service.

This risk is real, not theoretical. A complaint about a product sent from a foreign warehouse, purchased in a "Polish" store registered outside Poland, actually returns to the foreign wholesaler, and the consumer in most cases does not get their money back. UOKiK publicly warned in 2024 about CBD stores operating in this model.

Why are MLM schemes selling CBD a red flag number 7?

Multi-Level Marketing selling CBD appeared in Poland around 2019 and flourished after the pandemic. The Federal Trade Commission in the USA issued warning letters to CBD companies, including Curaleaf, in 2019 for using distributor networks to sell products with unlawful health claims. The mechanics of MLM reward the recruitment of distributors over product quality: the network usually has 4-7 levels of margin, so the final price includes compensation not only for the producer but for every intermediary. An oil that costs $30 at retail can reach the consumer through MLM for $90-150, even though its composition may be worse than products available in regular sales.

There are several signals of MLM in CBD sales: the seller encourages you to "become a distributor" and "earn on CBD", the price includes a "starter package" for the new distributor, the brand does not sell through physical stores or independent marketplaces, promotional materials emphasize "financial freedom" instead of product composition, and complaints require returns to the "upline", not to the company.

The economic test is simple: compare the price per milligram of CBD in the MLM product and in retail oil from a specialty store. If the difference is 3-5 times in favor of retail, you are dealing with a classic pyramid margin structure. The product itself may be safe, but you are overpaying for recruitment, not for the product's value.

How to recognize fake reviews in a CBD store (red flag number 8)?

Fake reviews are a plague in e-commerce, and the CBD category is particularly vulnerable due to the emotional shopping field. The Omnibus Directive (EU 2019/2161), implemented in Poland in 2023, requires sellers to inform whether published reviews come from verified buyers and what methods are used to ensure their authenticity. Publishing inauthentic reviews without purchase verification carries a penalty of up to 10% of the annual turnover of the entrepreneur and up to 2 million PLN for board members, and UOKiK has been regularly using these powers against online sellers since 2023.

Fake reviews in a CBD store reveal several signals: hundreds of 5-star ratings in a very short period, identical or very similar language formulas ("super product, I recommend it to everyone"), lack of product photos and specific application descriptions, authors without a history of other reviews with profiles created on the same day, and lack of negative ratings, even though the CBD category generates natural variability in experiences.

Free tools like Fakespot or ReviewMeta analyze review patterns and signal unnatural distributions, while Trustpilot and Opineo use partial purchase verification. The best sign of authenticity is reviews that are tonally diverse, containing both positives and minor critical remarks, along with photos of actual products in packaging. A CBD store with only maximum ratings and thousands of reviews in six months is a red flag, not a model to follow.

What does the law say about CBD: EFSA Health Claims and Regulation 1924/2006?

EU Regulation 1924/2006 regulates what nutritional and health claims may appear on food products, including supplements, and EFSA maintains a register of authorized claims. As of 2026, the register does not contain a single approved health claim for CBD. Moreover, CBD extracts are subject to EU Regulation 2015/2283 on novel food, and selling as a dietary supplement requires prior authorization from the European Commission. Nearly 200 applications regarding CBD as novel food have already been submitted to the Commission, some of which are still under EFSA evaluation, and none have yet been approved.

For the consumer, this means purchasing a product operating in a regulatory gray area: tolerated but not authorized. A producer pretending to have Novel Food authorization is lying. A producer using health claims on the packaging is breaking the law. Lack of authorization does not mean that CBD is "illegal", but it means that the consumer must take on part of the verification themselves.

The Chief Sanitary Inspectorate (GIS) supervises the food and supplement market, including labeling and safety, while UOKiK supervises market practices, consumer claims, and advertising. Both offices have significantly increased their activity in the CBD area since 2023, resulting in public warnings against several stores and brands.

What to expect from UOKiK warnings in 2026?

UOKiK's communications from 2024 indicate three main axes of supervision over the CBD market: health claims, transparency of consumer reviews, and cross-border sales practices. In 2026, further tightening of supervision can be expected, especially after the implementation of the Digital Services Act (DSA) and requirements for marketplace platforms.

The Polish consumer has specific tools: the right to withdraw from a distance contract within 14 days, the right to complain about non-compliance with the contract within 2 years, and the ability to report practices violating collective consumer interests to UOKiK. All of this is free and works effectively, and more and more consumers are actually using these tools instead of simply shrugging off the loss of several dozen zlotys.

Suspicious practices should be reported in specific places, depending on the nature of the problem:

• Office of Competition and Consumer Protection - complaints about market practices, unauthorized claims, fake reviews.
• GIS - food safety, faulty labeling, health claims.
• konsument.gov.pl - centrum pomocy konsumenta z formularzami online.
• Consumer Rights Ombudsman in your city - free legal assistance.

What are FDA warning letters and what do they mean for the Polish consumer?

The American Food and Drug Administration has been regularly issuing warning letters to companies selling CBD with unauthorized health claims since 2015, and the list is public and searchable on the website FDA. Many of these brands distribute products in Europe through online stores and marketplace platforms. The credibility test of a global brand takes 60 seconds: just type the company name plus "warning letter" into the search engine. If an FDA entry appears, the brand has previously been called to cease illegal claims. This is not always disqualification, but it provides context for assessing current declarations.

FDA warning letters concern several recurring categories: claims of curing cancer, Alzheimer's disease, or anxiety disorders, selling CBD in food (FDA has not authorized CBD as a food ingredient outside of the drug Epidiolex), offering CBD to children without a prescription outside of approved indications, and claims of effects comparable to prescription drugs.

In warning letters from 2022-2024, the FDA consistently indicated that selling CBD as a drug without authorization violates the Federal Food, Drug, and Cosmetic Act. The Polish consumer can treat a brand's presence on this list as a global warning signal, independent of Polish jurisdiction.

How to verify a CBD store in 5 minutes before purchasing?

A full verification of the store takes an average of 5-7 minutes and significantly reduces the risk of purchasing a counterfeit product. From our market observations, a significant portion of CBD stores in Polish Google do not pass the full checklist, and the Centre for Medicinal Cannabis (CMC UK, 2019) described a similar problem in the British market. This simple process saves nerves and money.

The verification checklist includes seven points: the footer of the page with the full company address, NIP and REGON, checking the company in KRS or CEIDG along with the date of establishment, the VAT white list with active accounts, availability of COA online or on request with a batch number matching the packaging, a return policy with 14 days to withdraw and a Polish return address, a phone or email contact answered in less than 24 hours, and reviews averaging 4.2-4.8 with a variety of content.

Send the seller a short message: "Can I get the COA for batch X visible on the packaging?", "What is the extraction method?", "What country does the raw material come from?" The quality of the responses says more than the marketing claims on the product page, and a solid seller will respond specifically within a few hours. If you are looking for a more in-depth version of this process, see our complete guide to purchasing CBD supplements in Poland and buyer's checklist with a full list of control questions.

What to do if you purchased a counterfeit or defective CBD product?

The first reaction to suspicion of a counterfeit is not panic, but a calm complaint process. According to the Consumer Rights Act of May 30, 2014, you have 2 years to report a non-compliance of the goods with the contract, and the seller must respond to the complaint within 14 days. A lack of response within this period means automatic acceptance of the complaint.

The step-by-step process looks like this: keep evidence, meaning the packaging, receipt or invoice, screenshots of the product page at the time of purchase, and the bottle with the remaining contents; submit a complaint to the seller in writing, specifically describing your doubts, such as the lack of COA or suspicion of isolate instead of full spectrum; wait 14 days for a response, as a lack of response means acceptance of the complaint; if you encounter a refusal, escalate the matter to the Consumer Rights Ombudsman or through the UOKiK form; and in case of suspected mislabeling, report the matter to GIS.

CBD scam stores often disappear from the internet within a few months of the first complaints. If you paid by card, you have the right to report a chargeback to the bank within 120 days, and banks in Poland accept the argument "goods not as described" or "seller disappeared" as grounds for a refund. If you are just choosing an oil, check our CBD oil category, where each product has batch documentation and data of the responsible Polish entity.

What role does Project CBD play in verifying the CBD market?

Project CBD is an independent non-profit organization established in 2010, monitoring the cannabinoid market and publishing analyses without ties to sellers. It has repeatedly pointed out that some products labeled as "full spectrum" in online sales are actually isolates, and separately maintains a database of drug interactions and open COA reviews, available free of charge to any consumer.

Other valuable sources include the Centre for Medicinal Cannabis in the UK, the European Industrial Hemp Association, and the Polish Institute of Natural Fibers and Medicinal Plants. Citing these sources in the manufacturer's communication is a good sign, as none of them sponsor commercial products or conduct their own sales, and their analyses are created independently of industry marketing budgets.

Red flags appear in the "authorities" cited by the sellers themselves:

• "Dr. Smith from the International Institute of Hemp" without a verifiable CV.
• Citations of studies without a DOI, date, and journal.
• Logos of "certificates" without a verification subpage.
• "Approved by wellness experts" without names and qualifications.

Summary: how to consciously buy CBD in Poland in 2026?

Natural CBD supplements in Poland are a category with real value and equally real risk of encountering a counterfeit, poorly labeled product, or one purchased in a toxic sales model. However, a conscious consumer in 2026 has more tools than ever before: company registers, the FDA Warning Letters database, COA from accredited laboratories, warnings from UOKiK and GIS, the Omnibus directive, and the right to chargeback at the bank.

The eight red flags discussed in this article cover most fraud scenarios: lack of COA, isolate pretending to be full spectrum, medical claims, suspiciously low price, lack of manufacturer data, hidden dropshipping, MLM, and fake reviews. Each of these signals alone should raise suspicion, and the combination of two or more signals is grounds to abandon the purchase.

Check our offer of verified hemp products in the u Bucha store. Each product undergoes an audit of documentation, manufacturer transparency, and COA compliance with the batch. If you are taking prescription medications, always consult CBD supplementation with your doctor or pharmacist due to possible interactions.

Frequently Asked Questions

How to recognize a fake COA for CBD oil?

A false COA usually lacks a batch number matching the packaging, lacks ISO 17025 accreditation, sampling date, analyst's name, and a full cannabinoid and contaminant profile. A study by the University of Pennsylvania (Bonn-Miller et al., JAMA, 2017) found that 69% of CBD products had labels inconsistent with their actual content, and many sellers attach a general PDF that does not correspond to the batch.

How to recognize a CBD isolate pretending to be full spectrum?

A true full spectrum oil has a dark green-brown color, an herbal and slightly bitter taste, and the COA shows CBG, CBN, CBC, and terpenes. A clear, colorless oil without a distinct aroma is usually an isolate suspended in MCT. Independent laboratories have repeatedly shown that some products labeled as full spectrum sold online actually contain only CBD.

Can a CBD manufacturer legally promise treatment in Poland?

No. EU Regulation 1924/2006 on health claims prohibits attributing properties of preventing, treating, or healing diseases to food. EFSA has not approved any health claims for CBD by 2026. Any promise of curing depression, cancer, or epilepsy on a CBD oil package is a violation of the law and one of the most serious warning signs.

Why is a very low price for CBD oil a warning signal?

The cost of producing 10 ml of 10% CBD oil (1000 mg) using CO2 extraction, with laboratory testing, is estimated on the market at several dozen zlotys net. Oil offered for 19-29 zlotys lacks a real economic basis for producing quality extract. It is usually seed oil without cannabinoids, an isolate without a COA, or a product from an unknown source.

What does the lack of manufacturer data on CBD packaging mean?

Every product placed on the market in the EU must have the name and address of the responsible entity on the packaging, in accordance with Regulation 1169/2011 for food and 1223/2009 for cosmetics. Lack of a company name, address, country of production, or batch number is a violation of EU law, and purchasing such a product means there is no path for complaints.

What is CBD dropshipping and why is it risky?

CBD dropshipping is a model in which the seller accepts payment and ships the product directly from an external warehouse, most often outside the EU. The consumer does not see the packaging or expiration date before purchase, the seller is not responsible for the quality of the batch, and complaints fall into a void. UOKiK has warned consumers about CBD stores without a clear Polish address.

Is MLM selling CBD oils always a scam?

Not always, but the MLM model rewards the recruitment of distributors over product quality. The FTC in the USA issued warning letters in 2019 to MLM companies selling CBD for unsubstantiated health claims. The final price in MLM usually includes 4-7 levels of margin, so the real value of the product can be several times lower than in retail. Always check the COA.

How to recognize fake reviews and ratings of CBD stores?

Signs of fake reviews include hundreds of 5-star ratings in a short time, identical language formulas, lack of product photos, and no verified purchase. The Omnibus Directive allows UOKiK to penalize sellers for publishing inauthentic reviews with fines of up to 10% of the company's annual turnover, and since 2023, the office has regularly used this power.

This article is for informational and educational purposes only and does not constitute legal advice. The legal status described in the article is valid as of the date of publication: regulations regarding CBD and hemp supplements may change. Before making a purchasing or legal decision, consult a lawyer or current legal acts.

Author: Michał Waluk · Opublikowano: 2026-05-11 · Aktualizacja: 2026-08-10